A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting Conditions
Status:
Completed
Trial end date:
1998-01-01
Target enrollment:
Participant gender:
Summary
To compare the relative bioavailability of gabapentin 400 mg capsules (Purepac) with that of
NEURONTIN® 400 mg capsules (Parke-Davis) in healthy adult male subjects under fasting
conditions